Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters

Country/Region as subject
Publication year range
1.
J Med Virol ; 92(10): 2130-2138, 2020 10.
Article in English | MEDLINE | ID: mdl-32410236

ABSTRACT

Rapid diagnosis and isolation are key to containing the quick spread of a pandemic agent like severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), which has spread globally since its initial outbreak in Wuhan province in China. SARS-CoV-2 is novel and the effect on typically prevalent seasonal viruses is just becoming apparent. We present our initial data on the prevalence of respiratory viruses in the month of March 2020. This is a retrospective cohort study post launching of SARS-CoV-2 testing at Baylor Scott and White Hospital (BSWH), Temple, Texas. Testing for SARS-CoV-2 was performed by real-time reverse transcription polymerase chain reaction assay and results were shared with State public health officials for immediate interventions. More than 3500 tests were performed during the first 2 weeks of testing for SARS-CoV-2 and identified 168 (4.7%) positive patients. Sixty-two (3.2%) of the 1912 ambulatory patients and 106 (6.3%) of the 1659 emergency department/inpatients tested were positive. The highest rate of infection (6.9%) was seen in patients aged 25 to 34 years, while the lowest rate of infection was seen among patients aged <25 years old (2%). County-specific patient demographic information was shared with respective public health departments for epidemiological interventions. Incidentally, this study showed that there was a significant decrease in the occurrence of seasonal respiratory virus infections, perhaps due to increased epidemiological awareness about SARS-CoV-2 among the general public, as well as the social distancing measures implemented in response to SARS-CoV-2. Data extracted for BSWH from the Centers for Disease Control and Prevention's National Respiratory and Enteric Virus Surveillance System site revealed that Influenza incidence was 8.7% in March 2020, compared with 25% in March 2019. This study was intended to provide an initial experience of dealing with a pandemic and the role of laboratories in crisis management. This study provided SARS-CoV-2 testing data from ambulatory and inpatient population. Epidemiological interventions depend on timely availability of accurate diagnostic tests and throughput capacity of such systems during large outbreaks like SARS-CoV-2.


Subject(s)
COVID-19/epidemiology , Disease Notification/statistics & numerical data , Pandemics , Respiratory Tract Infections/epidemiology , SARS-CoV-2/genetics , Adult , Aged , Aged, 80 and over , COVID-19/diagnosis , COVID-19/transmission , COVID-19/virology , COVID-19 Testing/methods , Epidemiological Monitoring , Female , Humans , Male , Middle Aged , Physical Distancing , Prevalence , Real-Time Polymerase Chain Reaction , Respiratory Tract Infections/diagnosis , Respiratory Tract Infections/transmission , Respiratory Tract Infections/virology , Retrospective Studies , Seasons , Texas/epidemiology
2.
Surg Neurol Int ; 14: 243, 2023.
Article in English | MEDLINE | ID: mdl-37560579

ABSTRACT

Background: Enterococcus faecalis is reported infrequently as an infectious cause of discitis. In the literature, the diagnosis is commonly made based on the clinical picture coupled with blood cultures, imaging, and tissue cultures. Case Description: A 62-year-old male with chronic lower back pain underwent lumbar decompression for a lumbar disc. At surgery, the patient had significant black discoloration of the disc material. Later, the cultures demonstrated E. faecalis infectious discitis. Conclusion: Here is an example of enterococcal lumbar discitis found during a routine lumbar discectomy. As operative cultures revealed E. faecalis, the patient required not one but two operations (i.e., second for seroma/ hematoma due to infection) following which antibiotic therapy eradicated the infection.

3.
JAMA Netw Open ; 5(9): e2233273, 2022 09 01.
Article in English | MEDLINE | ID: mdl-36156146

ABSTRACT

Importance: Pregnant people are at high risk for severe COVID-19 but were excluded from mRNA vaccine trials; data on COVID-19 vaccine effectiveness (VE) are needed. Objective: To evaluate the estimated effectiveness of mRNA vaccination against medically attended COVID-19 among pregnant people during Delta and Omicron predominance. Design, Setting, and Participants: This test-negative, case-control study was conducted from June 2021 to June 2022 in a network of 306 hospitals and 164 emergency department and urgent care (ED/UC) facilities across 10 US states, including 4517 ED/UC encounters and 975 hospitalizations among pregnant people with COVID-19-like illness (CLI) who underwent SARS-CoV-2 molecular testing. Exposures: Two doses (14-149 and ≥150 days prior) and 3 doses (7-119 and ≥120 days prior) of COVID-19 mRNA vaccine (≥1 dose received during pregnancy) vs unvaccinated. Main Outcomes and Measures: Estimated VE against laboratory-confirmed COVID-19-associated ED/UC encounter or hospitalization, based on the adjusted odds ratio (aOR) for prior vaccination; VE was calculated as (1 - aOR) × 100%. Results: Among 4517 eligible CLI-associated ED/UC encounters and 975 hospitalizations, 885 (19.6%) and 334 (34.3%) were SARS-CoV-2 positive, respectively; the median (IQR) patient age was 28 (24-32) years and 31 (26-35) years, 537 (12.0%) and 118 (12.0%) were non-Hispanic Black and 1189 (26.0%) and 240 (25.0%) were Hispanic. During Delta predominance, the estimated VE against COVID-19-associated ED/UC encounters was 84% (95% CI, 69% to 92%) for 2 doses within 14 to 149 days, 75% (95% CI, 5% to 93%) for 2 doses 150 or more days prior, and 81% (95% CI, 30% to 95%) for 3 doses 7 to 119 days prior; estimated VE against COVID-19-associated hospitalization was 99% (95% CI, 96% to 100%), 96% (95% CI, 86% to 99%), and 97% (95% CI, 79% to 100%), respectively. During Omicron predominance, for ED/UC encounters, the estimated VE of 2 doses within 14 to 149 days, 2 doses 150 or more days, 3 doses within 7 to 119 days, and 3 doses 120 or more days prior was 3% (95% CI, -49% to 37%), 42% (95% CI, -16% to 72%), 79% (95% CI, 59% to 89%), and -124% (95% CI, -414% to 2%), respectively; for hospitalization, estimated VE was 86% (95% CI, 41% to 97%), 64% (95% CI, -102% to 93%), 86% (95% CI, 28% to 97%), and -53% (95% CI, -1254% to 83%), respectively. Conclusions and Relevance: In this study, maternal mRNA COVID-19 vaccination, including booster dose, was associated with protection against medically attended COVID-19. VE estimates were higher against COVID-19-associated hospitalization than ED/UC visits and lower against the Omicron variant than the Delta variant. Protection waned over time, particularly during Omicron predominance.


Subject(s)
COVID-19 , Influenza Vaccines , Influenza, Human , Pregnancy Complications, Infectious , Adult , COVID-19/epidemiology , COVID-19/prevention & control , COVID-19 Vaccines , Case-Control Studies , Female , Humans , Influenza, Human/prevention & control , Pregnancy , Pregnancy Complications, Infectious/epidemiology , Pregnancy Complications, Infectious/prevention & control , RNA, Messenger, Stored , SARS-CoV-2/genetics , United States/epidemiology , Vaccines, Synthetic , mRNA Vaccines
4.
Med Mycol Case Rep ; 33: 21-25, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34295641

ABSTRACT

The standard of care for treatment of sino-orbital mucormycosis involves aggressive surgical debridement and liposomal amphotericin, and the roles of adjunctive and topical therapies are less clear. Here we describe a case of severe refractory sino-orbital mucormycosis in an immunocompetent patient who responded to combination therapy with liposomal amphotericin, isavuconazole, micafungin, and topical amphotericin deoxycholate after failing to achieve negative surgical margins.

7.
Adv Chronic Kidney Dis ; 26(1): 51-60, 2019 01.
Article in English | MEDLINE | ID: mdl-30876618

ABSTRACT

Chronic kidney disease patients are at high risk for infections because of multidrug-resistant organisms. Infections are the second most common cause of death in patients with ESRD. Patients with ESRD are prone to infections given alterations in immunity, increased rates of colonization with multidrug-resistant organisms, increased hospitalizations, and interactions with health care systems. Infections range from urinary tract infections, pneumonia, skin and soft tissue infections, central line-associated bloodstream infections to sepsis. A coordinated collaborative effort using a multipronged approach must be stressed to reduce the burden of infections. Preventive measures such as hand hygiene, antibiotic stewardship, immunizations, and minimizing central venous catheters are critical to curtail infections with multidrug-resistant organisms. Empirical and targeted treatment for multidrug-resistant organisms may require collaboration with infectious disease providers to improve outcomes in these serious infections. It is imperative to address multidrug-resistant organisms in ESRD patients at this juncture to improve medical outcomes now and for the future.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Bacterial Infections/prevention & control , Drug Resistance, Multiple, Bacterial , Kidney Failure, Chronic/therapy , Antimicrobial Stewardship , Bacterial Infections/drug therapy , Bacterial Infections/microbiology , Catheter-Related Infections/microbiology , Catheter-Related Infections/prevention & control , Disinfection , Hand Hygiene , Humans , Patient Isolation , Pneumonia/microbiology , Pneumonia/prevention & control , Renal Dialysis , Sepsis/microbiology , Sepsis/prevention & control , Urinary Tract Infections/microbiology , Urinary Tract Infections/prevention & control
8.
IDCases ; 15: e00500, 2019.
Article in English | MEDLINE | ID: mdl-30788216

ABSTRACT

Infection with nontyphoidal Salmonella is traditionally characterized by intestinal manifestations. However, extra-intestinal infections are known to occur, with purulent pericarditis associated with cardiac tamponade being rare. This case report is of a 57-year-old male with Crohn's disease initiated on infliximab therapy two months prior to presentation. He presented with recurrent chest pain and a single occurrence of fever. A Computed Tomography (CT) scan of the chest revealed a pericardial effusion. An echocardiogram confirmed the presence of the fluid with tamponade physiology, requiring immediate surgical decompression. The pericardial fluid culture grew Salmonella enterica, despite the patient having only a single episode of fever, disproportionate to the severity of the infection. Conceivably, the lack of systemic symptoms may be attributed to recent infliximab therapy. Upon conducting a literature review, immunosuppressive factors seem to play a significant role in nontyphoid Salmonella enterica pericardial effusion presenting with cardiac tamponade.

9.
IDCases ; 18: e00612, 2019.
Article in English | MEDLINE | ID: mdl-31463196

ABSTRACT

Cryptococcus species (other than Cryptococcus neoformans) have been labeled as saprophytic and nonpathogenic in immunocompetent individuals in the past. In recent years, infections caused by non-neoformans Cryptococcus species have been recognized. Cryptococcus laurentii is known to be a rare human pathogen. In this case report, we present a 59-year-old man who did not have HIV infection with meningoencephalitis caused by Cryptococcus laurentii. No significant underlying immunosuppressive disorder was found. The only identifiable risk factors were that the patient was a farmer with previous exposure to pigeon droppings. Here, we describe what we believe to be the fifth reported case of meningitis caused by Cryptococcus laurentii.

10.
Diagn Microbiol Infect Dis ; 51(2): 131-3, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15698719

ABSTRACT

Vibrio vulnificus is a Gram-negative bacterium that causes an aggressive infection with high mortality, especially in patients with liver disease. Wound infections due to V. vulnificus occur via direct contamination of cutaneous tissues and can include the uterus. We report a case of V. vulnificus tubo-ovarian infection from an unusual method of acquisition in the Gulf of Mexico.


Subject(s)
Abscess/diagnosis , Fallopian Tube Diseases/diagnosis , Ovarian Diseases/diagnosis , Vibrio Infections/diagnosis , Vibrio vulnificus/isolation & purification , Abscess/therapy , Adult , Anti-Bacterial Agents , Drainage/methods , Drug Therapy, Combination/therapeutic use , Fallopian Tube Diseases/therapy , Female , Follow-Up Studies , Humans , Ovarian Diseases/therapy , Risk Assessment , Severity of Illness Index , Treatment Outcome , Vibrio Infections/drug therapy
11.
Am J Infect Control ; 43(5): 533-6, 2015 May 01.
Article in English | MEDLINE | ID: mdl-25769618

ABSTRACT

Health care-acquired infections are a major contributor of mortality; therefore, prevention of these infections is a priority. Hand hygiene compliance among health care workers is low. We report the process at our institution to increase the hand hygiene compliance rate (HHCR).We implemented interventions over 6 months. The periods were divided into preintervention, intervention, and postintervention, and the monthly HHCR was calculated. The primary objective was to measure the HHCR after the intervention period and ensure sustainability. There were 25,372 observations, with 22,501 compliant events, for an overall HHCR of 88.7%. The HHCR improved over time (preintervention, 72.7%; invention, 79.7%; postintervention, 93.2%), with significance between pre-and postintervention periods (P < .002). The HHCR stabilized after all interventions and was sustained over 22 months. Our study highlights a multifaceted intervention, including administrative leadership, that led to an increase in the HHCR. Institutions should individualize their multimodal approach to include administrative leadership to achieve a high, sustained HHCR.


Subject(s)
Cross Infection/prevention & control , Guideline Adherence , Hand Hygiene/methods , Infection Control/methods , Humans
12.
Clin Infect Dis ; 39(11): 1724-9, 2004 Dec 01.
Article in English | MEDLINE | ID: mdl-15578378

ABSTRACT

Hepatitis C is one of the leading causes of liver disease in the United States, and current recommendations for its treatment include the use of interferon (IFN). Pulmonary side effects, although uncommon, have been reported in association with the use of IFN. We report a case of interstitial granulomatous pneumonitis that occurred after therapy with IFN and ribavirin, and we review the literature concerning this entity and other forms of IFN-associated pulmonary toxicity in patients with hepatitis C. The purpose of the present study is to increase awareness of the unusually wide spectrum of pulmonary toxicities associated with the use of IFN and ribavirin, with the anticipation that IFN will be used more frequently in the future for the treatment of hepatitis C.


Subject(s)
Antiviral Agents/adverse effects , Granuloma/chemically induced , Hepatitis C/drug therapy , Interferons/adverse effects , Lung Diseases, Interstitial/chemically induced , Ribavirin/adverse effects , Aged , Female , Granuloma/complications , Humans , Lung Diseases, Interstitial/complications
13.
Clin Chest Med ; 35(4): 697-712, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25453419

ABSTRACT

Immunosuppression predisposes the host to development of pulmonary infections, which can lead to respiratory failure and the development of acute respiratory distress syndrome (ARDS). There are multiple mechanisms by which a host can be immunosuppressed and each is associated with specific infectious pathogens. Early invasive diagnostic modalities such as fiber-optic bronchoscopy with bronchoalveolar lavage, transbronchial biopsy, and open lung biopsy are complementary to serologic and noninvasive studies and assist in rapidly establishing an accurate diagnosis, which allows initiation of appropriate therapy and may improve outcomes with relative safety.


Subject(s)
Immunocompromised Host , Respiratory Distress Syndrome/diagnosis , Bronchi/pathology , Bronchoalveolar Lavage , Bronchoscopy , Fiber Optic Technology , Humans , Lung/pathology , Respiratory Distress Syndrome/complications
14.
Am J Med Sci ; 346(5): 422-3, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23811577

ABSTRACT

Extraintestinal manifestatation such as prosthetic joint infection due to Clostridium difficile is a rare diagnosis. A 47-year-old female patient presented with chronic pain in left shoulder prosthetic joint. Plain roentgenogram of left shoulder prosthetic joint revealed anterior dislocation and loosening of prosthesis. The synovial fluid cultures and intraoperative deep joint cultures repeatedly grew Clostridium difficile. Patient was treated with antimicrobial therapy and surgical debridement with complete removal of hardware and revision arthroplasty.


Subject(s)
Clostridioides difficile/isolation & purification , Enterocolitis, Pseudomembranous/complications , Joint Prosthesis/microbiology , Prosthesis-Related Infections/microbiology , Shoulder Joint/microbiology , Anti-Infective Agents/therapeutic use , Arthroplasty, Replacement , Debridement , Enterocolitis, Pseudomembranous/diagnosis , Female , Humans , Middle Aged , Prosthesis Failure/etiology , Prosthesis-Related Infections/complications , Prosthesis-Related Infections/therapy , Reoperation , Shoulder Dislocation/etiology , Synovial Fluid/microbiology , Treatment Outcome
15.
BMJ Case Rep ; 20132013 Mar 05.
Article in English | MEDLINE | ID: mdl-23462652

ABSTRACT

Spontaneous non-traumatic Escherichia coli meningitis is very rare in adults. We report a case of a 48-year-old woman with Marfan's syndrome with E coli meningitis. Apparently, the relation between an increased risk of meningitis and Marfan's syndrome is not well known. This patient was discharged on intravenous antibiotic therapy after a diagnosis of E coli meningitis without looking for the cause by imaging studies previously. Her blood cultures were negative ruling out haematogenous spread. Our work-up revealed extensive dural ectasia with intrasacral meningoceles extending into the pelvis possibly acting as a portal of entry for the bacteria into the brain from the gastrointestinal tract.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Escherichia coli Infections/diagnosis , Escherichia coli Infections/drug therapy , Marfan Syndrome/complications , Meningitis/diagnosis , Meningitis/drug therapy , Meningitis/microbiology , Diagnosis, Differential , Diagnostic Imaging , Female , Humans , Middle Aged
16.
Med Mycol ; 43(7): 651-5, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16396251

ABSTRACT

Aspergillus scleritis is a potentially devastating ocular infection difficult to treat because of poor scleral vascularity. Most Aspergillus cases occur following ocular surgery, but others have been associated with trauma or intravenous drug use. No anti-fungal agents are consistently efficacious in the treatment of scleral fungal infections. We report a case of Aspergillus scleritis successfully treated with a combination of voriconazole and caspofungin, as well as a review of the literature concerning treatment of Aspergillus scleritis.


Subject(s)
Aspergillosis/drug therapy , Aspergillus flavus , Eye Infections, Fungal/drug therapy , Peptides, Cyclic/therapeutic use , Pyrimidines/therapeutic use , Scleritis/drug therapy , Triazoles/therapeutic use , Antifungal Agents/therapeutic use , Aspergillosis/diagnosis , Caspofungin , Echinocandins , Eye Infections, Fungal/diagnosis , Female , Humans , Lipopeptides , Middle Aged , Scleritis/diagnosis , Treatment Outcome , Voriconazole
SELECTION OF CITATIONS
SEARCH DETAIL